CALR and melanoma: Using 2 independent shRNA sequences targeting CRT mRNA, we achieved significant levels of CRT silencing at the mRNA and protein levels in 3 independent patient-derived melanoma cell cultures (Mel727, Mel1626, and Mel525; Figs 1A and 1B and S1A and S1B, lower panel).